Skip to main content

Shuttle Pharmaceuticals Holdings, Inc.

SHPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001757499

In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Shuttle Pharmaceuticals Holdings, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of SHPH: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders011+11
Shares0504.3K+504.3K
Value$0$2.32M+$2.32M

New holders (11)

Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to SHPH in Q3 2022
InstitutionSharesValue% of portfolio
BlackRock Inc.308,137$1.41M0.00%
Qube Research & Technologies Ltd39,100$179.0K0.00%
UBS Group AG33,950$156.0K0.00%
Two Sigma Investments, LP32,808$151.0K0.00%
Millennium Management LLC29,743$137.0K0.00%
Jane Street Group, LLC20,968$96.0K0.00%
Virtu Financial LLC17,048$78.0K0.01%
HSBC Holdings PLC13,737$67.0K0.00%
Barclays PLC8,410$39.0K0.00%
Federation des caisses Desjardins du Quebec400$1.84K0.00%
Royal Bank of Canada1$00.00%

Sold out (0)

Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

None.